Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1042/CS20210879

http://scihub22266oqcxt.onion/10.1042/CS20210879
suck pdf from google scholar
35621124!9429452!35621124
unlimited free pdf from europmc35621124    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid35621124      Clin+Sci+(Lond) 2022 ; 136 (10): 747-769
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Pathogenesis of pneumonia and acute lung injury #MMPMID35621124
  • Long ME; Mallampalli RK; Horowitz JC
  • Clin Sci (Lond) 2022[May]; 136 (10): 747-769 PMID35621124show ga
  • Pneumonia and its sequelae, acute lung injury, present unique challenges for pulmonary and critical care healthcare professionals, and these challenges have recently garnered global attention due to the ongoing Sars-CoV-2 pandemic. One limitation to translational investigation of acute lung injury, including its most severe manifestation (acute respiratory distress syndrome, ARDS) has been heterogeneity resulting from the clinical and physiologic diagnosis that represents a wide variety of etiologies. Recent efforts have improved our understanding and approach to heterogeneity by defining sub-phenotypes of ARDS although significant gaps in knowledge remain. Improving our mechanistic understanding of acute lung injury and its most common cause, infectious pneumonia, can advance our approach to precision targeted clinical interventions. Here, we review the pathogenesis of pneumonia and acute lung injury, including how respiratory infections and lung injury disrupt lung homoeostasis, and provide an overview of respiratory microbial pathogenesis, the lung microbiome, and interventions that have been demonstrated to improve outcomes-or not-in human clinical trials.
  • |*Acute Lung Injury/etiology/pathology[MESH]
  • |*COVID-19[MESH]
  • |*Pneumonia[MESH]
  • |*Respiratory Distress Syndrome/etiology[MESH]
  • |Humans[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box